MOLECULAR MECHANISMS OF MICROBIAL RESISTANCE: IMPLICATIONS FOR BIOTECHNOLOGY AND DRUG DEVELOPMENT

Abstract

Antimicrobial resistance (AMR) has emerged as a significant biological and therapeutic issue, compromising the efficacy of currently available antibiotics and enhancing the frequency of infections that are challenging to treat in the world. This paper explores the molecular understanding of microbial resistance and its application to biotechnology and drug development with an experimental dataset of antimicrobial resistance data at the level of gene-level resistance determinants, resistance-class indicators, and genomic variables. Quantitative analytical design was used to analyze the distribution of resistance genes, categorize them into functional molecular groups and examine co-occurrence relationships that are linked to multidrug resistance. The analysis showed that the burden of resistance against all the microbial isolates was consistently high as indicated by the high number of antimicrobial resistance genes and resistance classes that were identified per isolate. Classification using mechanism revealed that efflux-mediated resistance was the pathway, enzymatic degradation, membrane-associated resistance, and target modification or protection. The concomitant presence of several resistance determinants also showed that the organization of resistance is through combined molecular mechanisms as opposed to single gene action. These trends suggest that there are stable multidrug resistance structures in the isolates investigated. This paper has indicated the importance of mechanism-based resistance analysis in biotechnology especially in resistance profiling, genomic interpretation and therapeutic targeting. In terms of drug development, the results highlight the need to focus on the main mechanisms like efflux systems or enzymes that inactivate drugs to enhance antimicrobial efficacy.